SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intels weak fourth-quarter outlook overshadowed its quarterly results, with soft PC demand and manufacturing constraints weighing on expectations and prompting analyst downgrades. Traders are divided between calling the selloff an overreaction and expecting further declines.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A sharp Nasdaq and technology-stock selloff, amid concerns about AI valuations, heavy infrastructure spending and disappointing tech earnings, is driving discussion; Intels plunge is a frequent focus. Traders are split between expecting further losses and viewing the decline as an oversold correction, while claims of forced liquidations and geopolitical or election-related triggers remain speculative.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisks sharp selloff despite beating earnings expectations, raising guidance and announcing a stock split dominates discussion, with traders pointing to broad tech and memory-stock weakness and fears that memory pricing and earnings growth may be nearing a cyclical peak. Many view the drop as an overreaction and are buying the dip, while others argue slowing growth and the memory cycle justify caution.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 76,874.98691422 USD and is down -4.82 over the last 24 hours. It is currently trading on 12773 active market(s) with $58,826,736,014.03 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

A reported Binance security breach and temporary withdrawal suspension have fueled selling and fears of contagion across crypto, adding pressure to Bitcoin amid a broader risk-off move. Traders disagree on whether the incident signals deeper exchange risks and more downside or is a buying opportunity, noting that Bitcoin itself was not directly hacked.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit shares plunged after its quarterly report paired strong results with a softer revenue outlook, slowing user growth and warnings that declining Google search referrals could pressure traffic; plans to test a logged-in-first experience added concern about losing casual visitors. Traders debate whether the selloff is an overreaction to temporary headwinds or reflects a deeper threat to Reddits user growth and advertising model.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp semiconductor and tech selloff, led in part by Intels weak outlook and concerns about AI/PC demand, has hammered SOXLs 3x leveraged exposure. Traders are split between buying the dip for a relief bounce and warning that sector weakness and leverage-driven losses could deepen.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CRMD is drawing attention after a sharp selloff tied to DaVitas warning that DefenCaths post-TDAPA reimbursement contribution could fall significantly after Q1 2027, raising concerns about future adoption and revenue. Traders disagree over whether DaVitas preliminary estimate signals a real commercial risk or is outweighed by CMSs reimbursement outlook; some view the decline as an overreaction.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

IOVAs sharp selloff followed updated lifileucel lung-cancer trial data: the overall response rate was roughly in line with the prior update, while a retrospective biomarker-selected subgroup showed a much higher response rate, leaving investors debating the narrower opportunity, uncertain durability and FDA path. Traders also criticized managements presentation; some see the reaction as excessive and the precision-treatment strategy as promising, while others remain concerned about delayed validation and lost confidence in management.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

The move to a fresh 52-week high is centered on Q3 earnings expectations and continued BRIUMVI growth. Traders also speculate that buyout interest or short covering may be adding to momentum, though no acquisition is confirmed.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

DIA is under pressure amid a broad market selloff, with traders citing rising oil prices and escalating Middle East tensions alongside scrutiny of tech earnings and AI spending. The discussion is broadly bearish, though some traders point to market rotation and see pullbacks as buying opportunities.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MiMedx-Sanara Merger Faces Fresh Regulatory Obstacle – SMTI Stock Falls Below This Key Support Level For The First Time In 4 Months

Equity

The Federal Trade Commission issued a Second Request on Friday, seeking additional documents and information from both companies for the merger.


Are SMTI, LAB, ATKR, VAL Obtaining Fair Deals for their Shareholders?

Are SMTI, LAB, ATKR, VAL Obtaining Fair Deals for their Shareholders? Are SMTI, LAB, ATKR, VAL Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Sept. 11, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Sanara MedTech Inc. (NASDAQ: SMTI) to MiMedx Group, Inc. for $33.00 in cash and 0.4735 shares of MiMedx common stock for each share of Sanara common stock.Halper Sadeh encourages Sanara shareholders to click here to learn...

Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates

Sanara MedTech (SMTI) delivered earnings and revenue surprises of +150.00% and -4.30%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Are MKTX, SMTI, FBRX, LXFR Obtaining Fair Deals for their Shareholders?

Are MKTX, SMTI, FBRX, LXFR Obtaining Fair Deals for their Shareholders? Are MKTX, SMTI, FBRX, LXFR Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 6, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

biote Corp. (BTMD) Reports Break-Even Earnings for Q2

biote Corp. (BTMD) delivered earnings and revenue surprises of -100.00% and -5.71%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--FBRX, LXFR, SMTI, and MKTX

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--FBRX, LXFR, SMTI, and MKTX $HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--FBRX, LXFR, SMTI, and MKTX PR Newswire NEW YORK, Aug. 5, 2026 NEW YORK, Aug. 5, 2026 /PRNewswire/ -- Class...

Are MKTX, SMTI, LPSN Obtaining Fair Deals for their Shareholders?

Are MKTX, SMTI, LPSN Obtaining Fair Deals for their Shareholders? Are MKTX, SMTI, LPSN Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 3, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sanara MedTech Inc. (NASDAQ: SMTI)

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sanara MedTech Inc. (NASDAQ: SMTI) $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sanara MedTech Inc. (NASDAQ: SMTI) PR Newswire NEW YORK, July 30, 2026 NEW YORK, July 30, 2026 /PRNewswire...

Shareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for Public Shareholders

Shareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for Public Shareholders Shareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for Public Shareholders PR Newswire MILWAUKEE, July 30, 2026 MILWAUKEE, July 30...

Sanara MedTech, Inc. engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.

Sanara MedTech Inc

Neutral Sentiment

<ul class="summary-bullets"><li>The request extends the mandatory waiting period to 30 days after both companies comply.</li><li>In July, MiMedx agreed to acquire Sanara in a cash-and-stock transaction at $35 per share.</li><li>The transaction was expected to close by the end of the year.</li></ul>Shares of Sanara MedTech (SMTI) and MiMedx Group (MDXG) slumped on Friday after a regulatory&nbsp;request regarding their proposed merger to form a regenerative medicine company.The Federal Trade Commission (FTC) issued a Second Request, seeking additional documents and information from both companies as part of its antitrust review, raising uncertainty about the timeline for the deal's closure.The request extends the mandatory waiting period to 30 days after both companies comply. The latest development could delay the merger beyond its original year-end target.<a href="https://stocktwits.com/symbol/SMTI">SMTI stock</a> was down 5.5%, dropping below its 50-day moving average (50-DMA) for the first time since June. Meanwhile, <a href="https://stocktwits.com/symbol/MDXG">MDXG shares</a>, which were also testing their 50-DMA, were down 2.8%.<h2 class="st-heading-2">MDXG, SMTI Expect $400M Revenue In FY2027</h2>In July, MiMedx&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.sec.gov/Archives/edgar/data/714256/000149315226035196/ex99-1.htm">agreed&nbsp;</a>to acquire Sanara in a cash-and-stock transaction at $35 per share. Sanara shareholders will receive $33 in cash and 0.4735 MiMedx shares for each share held.MiMedx said the combination aims to create a larger regenerative medicine company that caters to multiple surgical specialties, including wound care, soft-tissue repair, and bone fixation.MiMedx expects the acquisition to nearly double its surgical revenue and generate more than $20 million in annual cost savings. The combined business is targeting over $400 million in full-year 2027 revenue and adjusted earnings before interest, tax, depreciation and amortization (EBITDA) margin above 20%.<h2 class="st-heading-2">Retail Remains Bearish On MDXG, SMTI</h2>Retail sentiment surrounding both MDXG and SMTI on Stocktwits remained in the ‘bearish’ territory over the past 24 hours, amid ‘high’ message volumes.The stocks have had a contrasting 2026 so far, with SMTI shares gaining more than 44% while MDXG stock has slumped nearly 30%.Also read: <a href="https://stocktwits.com/news-articles/markets/equity/lilly-foundayo-pill-gets-european-regulatory-backing-lly-stock/cZxK4fORBso">Lilly’s Foundayo Pill Gets European Regulatory Backing – LLY Stock Heads For Best Week In Nearly Four Months</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

WASHINGTON, DC - JUNE 3: A sign is displayed on the Federal Trade Commission (FTC) Building on June 3, 2026 in Washington, DC. (Photo by Kevin Carter/Getty Images)

The request extends the mandatory waiting period to 30 days after both companies comply.

Mimedx Group Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$32.77
Prev Close	$32.92
Open	$33.19
Dividend Yield	0.00%
50-Day Moving Average	$34.54
Beta	1.31
Avg. Volume	203,679.36
PE Ratio	-8.88

52-Week High	$35.52
52-Week Low	$16.05
Market Capitalization	$302.42M
EPS (Annual)	-$4.36
Price to Book	38.09
Revenue Per Employee	$954,796.13

Feed

News

Sentiment

Earnings

Fundamentals

Info

SMTI Fundamentals